Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.80099139 |
2 | modulation by symbiont of host immune response (GO:0052553) | 7.80099139 |
3 | positive regulation by symbiont of host defense response (GO:0052509) | 7.80099139 |
4 | modulation by symbiont of host defense response (GO:0052031) | 7.80099139 |
5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.80099139 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.80099139 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.57735356 |
8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.26647191 |
9 | neutrophil activation involved in immune response (GO:0002283) | 6.21427621 |
10 | microglial cell activation (GO:0001774) | 5.98764492 |
11 | macrophage activation involved in immune response (GO:0002281) | 5.88998914 |
12 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.50121049 |
13 | positive regulation of interferon-alpha production (GO:0032727) | 5.25308306 |
14 | negative regulation of interleukin-12 production (GO:0032695) | 5.19748334 |
15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.14180957 |
16 | response to host immune response (GO:0052572) | 5.14180957 |
17 | regulation of interferon-alpha production (GO:0032647) | 4.98554387 |
18 | response to peptidoglycan (GO:0032494) | 4.92015832 |
19 | macrophage activation (GO:0042116) | 4.89442247 |
20 | regulation of mononuclear cell migration (GO:0071675) | 4.67361767 |
21 | immunoglobulin mediated immune response (GO:0016064) | 4.61955401 |
22 | positive regulation of antigen processing and presentation (GO:0002579) | 4.57617754 |
23 | response to host (GO:0075136) | 4.52496075 |
24 | response to host defenses (GO:0052200) | 4.52496075 |
25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.52496075 |
26 | eosinophil chemotaxis (GO:0048245) | 4.35646702 |
27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.26943202 |
28 | negative regulation of cell killing (GO:0031342) | 4.26943202 |
29 | myeloid cell activation involved in immune response (GO:0002275) | 4.26469493 |
30 | detection of other organism (GO:0098543) | 4.20407860 |
31 | granulocyte activation (GO:0036230) | 4.16492499 |
32 | respiratory burst (GO:0045730) | 4.12885037 |
33 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.08705107 |
34 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.02393793 |
35 | neutrophil activation (GO:0042119) | 4.02358267 |
36 | detection of external biotic stimulus (GO:0098581) | 3.93375784 |
37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.92882628 |
38 | regulation of antigen processing and presentation (GO:0002577) | 3.92172361 |
39 | cellular extravasation (GO:0045123) | 3.89823990 |
40 | pinocytosis (GO:0006907) | 3.89529791 |
41 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.86932311 |
42 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.84998185 |
43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.84871338 |
44 | eosinophil migration (GO:0072677) | 3.81018230 |
45 | regulation of gamma-delta T cell activation (GO:0046643) | 3.72940858 |
46 | detection of bacterium (GO:0016045) | 3.72352124 |
47 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.68679384 |
48 | detection of molecule of bacterial origin (GO:0032490) | 3.66052223 |
49 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.62465712 |
50 | detection of biotic stimulus (GO:0009595) | 3.62348328 |
51 | monocyte chemotaxis (GO:0002548) | 3.59575213 |
52 | positive regulation of interferon-beta production (GO:0032728) | 3.56826559 |
53 | I-kappaB phosphorylation (GO:0007252) | 3.55645355 |
54 | positive regulation of mast cell activation (GO:0033005) | 3.55254477 |
55 | regulation of mast cell degranulation (GO:0043304) | 3.48675371 |
56 | negative regulation of mast cell activation (GO:0033004) | 3.45956129 |
57 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.38940930 |
58 | regulation of macrophage chemotaxis (GO:0010758) | 3.38573526 |
59 | negative regulation of interleukin-17 production (GO:0032700) | 3.38481129 |
60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.35973659 |
61 | regulation of tolerance induction (GO:0002643) | 3.34014288 |
62 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.32459572 |
63 | positive regulation of lymphocyte migration (GO:2000403) | 3.32159456 |
64 | regulation of T cell tolerance induction (GO:0002664) | 3.31755275 |
65 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.30924155 |
66 | response to muramyl dipeptide (GO:0032495) | 3.30640577 |
67 | positive regulation of mast cell degranulation (GO:0043306) | 3.30611091 |
68 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.30611091 |
69 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.29761947 |
70 | regulation of mast cell activation (GO:0033003) | 3.29348671 |
71 | myeloid leukocyte activation (GO:0002274) | 3.28224663 |
72 | glycosphingolipid catabolic process (GO:0046479) | 3.26884153 |
73 | lymphocyte chemotaxis (GO:0048247) | 3.25213984 |
74 | phagocytosis, engulfment (GO:0006911) | 3.21242613 |
75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.17304425 |
76 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15910772 |
77 | B cell mediated immunity (GO:0019724) | 3.12480095 |
78 | positive regulation of type 2 immune response (GO:0002830) | 3.12438458 |
79 | T-helper 1 type immune response (GO:0042088) | 3.07417594 |
80 | superoxide anion generation (GO:0042554) | 3.05819626 |
81 | natural killer cell mediated immunity (GO:0002228) | 3.04019412 |
82 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.04019412 |
83 | regulation of monocyte chemotaxis (GO:0090025) | 3.03813526 |
84 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.03182175 |
85 | amino sugar catabolic process (GO:0046348) | 3.03055092 |
86 | cytidine catabolic process (GO:0006216) | 3.02620157 |
87 | cytidine deamination (GO:0009972) | 3.02620157 |
88 | cytidine metabolic process (GO:0046087) | 3.02620157 |
89 | oligosaccharide catabolic process (GO:0009313) | 2.99140463 |
90 | neutrophil mediated immunity (GO:0002446) | 2.98675010 |
91 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.97469637 |
92 | glycolipid catabolic process (GO:0019377) | 2.92165038 |
93 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.91435742 |
94 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.90812627 |
95 | response to interferon-alpha (GO:0035455) | 2.90773853 |
96 | defense response to protozoan (GO:0042832) | 2.89968147 |
97 | positive regulation of leukocyte degranulation (GO:0043302) | 2.89028334 |
98 | phagosome maturation (GO:0090382) | 2.87911449 |
99 | regulation of hypersensitivity (GO:0002883) | 2.86722789 |
100 | positive regulation of chemokine secretion (GO:0090197) | 2.86375647 |
101 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.84921711 |
102 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.84595430 |
103 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.83329136 |
104 | positive regulation of macrophage cytokine production (GO:0060907) | 2.83227663 |
105 | N-acetylneuraminate metabolic process (GO:0006054) | 2.82496918 |
106 | regulation of leukocyte degranulation (GO:0043300) | 2.82177592 |
107 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81493029 |
108 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.80846329 |
109 | type I interferon signaling pathway (GO:0060337) | 2.79777787 |
110 | cellular response to type I interferon (GO:0071357) | 2.79777787 |
111 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.78076249 |
112 | positive regulation of T cell migration (GO:2000406) | 2.78065829 |
113 | positive regulation of macrophage differentiation (GO:0045651) | 2.77535430 |
114 | intracellular pH reduction (GO:0051452) | 2.77457113 |
115 | negative regulation of granulocyte differentiation (GO:0030853) | 2.77061540 |
116 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.76993641 |
117 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76725710 |
118 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.76623601 |
119 | mast cell activation (GO:0045576) | 2.76204124 |
120 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.75735119 |
121 | negative regulation of T cell mediated immunity (GO:0002710) | 2.75335338 |
122 | response to type I interferon (GO:0034340) | 2.75261258 |
123 | myeloid dendritic cell activation (GO:0001773) | 2.74215064 |
124 | lymphocyte mediated immunity (GO:0002449) | 2.74071182 |
125 | response to protozoan (GO:0001562) | 2.73255384 |
126 | cellular response to interferon-gamma (GO:0071346) | 2.72977915 |
127 | leukocyte mediated cytotoxicity (GO:0001909) | 2.72431726 |
128 | regulation of lymphocyte migration (GO:2000401) | 2.71662808 |
129 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.71025396 |
130 | neutrophil chemotaxis (GO:0030593) | 2.69881725 |
131 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.67123013 |
132 | granulocyte chemotaxis (GO:0071621) | 2.66424643 |
133 | positive regulation of interleukin-6 production (GO:0032755) | 2.66334500 |
134 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.66168054 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.73449716 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.39084388 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.15787383 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 5.14900181 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.69824221 |
6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.21977182 |
7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.84291971 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.53765269 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.28952726 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97017203 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82614349 |
12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.57892567 |
13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.41110343 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.32551931 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.31024517 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25989785 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.23003841 |
18 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.20535461 |
19 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.19375534 |
20 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.18566791 |
21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.11008923 |
22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99459981 |
23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.94478999 |
24 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.86294125 |
25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83438623 |
26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83308178 |
27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82915676 |
28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81933925 |
29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.81390642 |
30 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69847997 |
31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61975529 |
32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61456685 |
33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59660269 |
34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53914789 |
35 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50224811 |
36 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.47854767 |
37 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42622124 |
38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42485950 |
39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42282981 |
40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39494848 |
41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35157246 |
42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31031161 |
43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29870893 |
44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25331291 |
45 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24247296 |
46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18838168 |
47 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17930348 |
48 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17511308 |
49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16377979 |
50 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13783051 |
51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11732438 |
52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11600147 |
53 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.10796925 |
54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10776957 |
55 | MYB_26560356_Chip-Seq_TH2_Human | 1.10204301 |
56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09057482 |
57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08921549 |
58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07439262 |
59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06763020 |
60 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.06613970 |
61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05431811 |
62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02836778 |
63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01023335 |
64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01023335 |
65 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99659103 |
66 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98910582 |
67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98050153 |
68 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97086379 |
69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97069796 |
70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95160529 |
71 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93350655 |
72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93244164 |
73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89954308 |
74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89546005 |
75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89063036 |
76 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88862646 |
77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84157684 |
78 | CJUN_26792858_Chip-Seq_BT549_Human | 0.83632178 |
79 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83245617 |
80 | MAF_26560356_Chip-Seq_TH2_Human | 0.82379841 |
81 | MAF_26560356_Chip-Seq_TH1_Human | 0.82089150 |
82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80912390 |
83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80808228 |
84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80616295 |
85 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.79254336 |
86 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.79155345 |
87 | MYB_26560356_Chip-Seq_TH1_Human | 0.79128669 |
88 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.78156907 |
89 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77329326 |
90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77058608 |
91 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76989695 |
92 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.75952708 |
93 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.74018481 |
94 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73761859 |
95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73619698 |
96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73579554 |
97 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.72965736 |
98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.72776078 |
99 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72332006 |
100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72041889 |
101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.70027459 |
102 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.69814890 |
103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69569899 |
104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.69158961 |
105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69028375 |
106 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.68658330 |
107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.68440332 |
108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67925423 |
109 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.67799785 |
110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67425161 |
111 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.66444947 |
112 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.66032143 |
113 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.65926926 |
114 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.64526317 |
115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64365236 |
116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.62331505 |
117 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.60656960 |
118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.59805304 |
119 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.59691610 |
120 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.58267281 |
121 | TP53_16413492_ChIP-PET_HCT116_Human | 0.57343700 |
122 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.57087547 |
123 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.57078006 |
124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.55483267 |
125 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.54925712 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 4.99161815 |
2 | MP0001835_abnormal_antigen_presentation | 4.67401263 |
3 | MP0002148_abnormal_hypersensitivity_rea | 3.64427380 |
4 | MP0006082_CNS_inflammation | 3.61215488 |
5 | MP0003436_decreased_susceptibility_to | 3.56120270 |
6 | MP0002419_abnormal_innate_immunity | 3.39338719 |
7 | MP0003172_abnormal_lysosome_physiology | 3.24880886 |
8 | MP0005000_abnormal_immune_tolerance | 3.11254052 |
9 | MP0003303_peritoneal_inflammation | 3.01133838 |
10 | MP0009785_altered_susceptibility_to | 2.88256751 |
11 | MP0000569_abnormal_digit_pigmentation | 2.87641439 |
12 | MP0001790_abnormal_immune_system | 2.68102026 |
13 | MP0005387_immune_system_phenotype | 2.68102026 |
14 | MP0005025_abnormal_response_to | 2.66740061 |
15 | MP0009840_abnormal_foam_cell | 2.63650331 |
16 | MP0002452_abnormal_antigen_presenting | 2.59089056 |
17 | MP0001800_abnormal_humoral_immune | 2.38549569 |
18 | MP0002723_abnormal_immune_serum | 2.37542604 |
19 | MP0003690_abnormal_glial_cell | 2.31936574 |
20 | MP0002277_abnormal_respiratory_mucosa | 2.28033646 |
21 | MP0005671_abnormal_response_to | 2.23968087 |
22 | MP0003724_increased_susceptibility_to | 2.18375851 |
23 | MP0005464_abnormal_platelet_physiology | 2.14210599 |
24 | MP0001533_abnormal_skeleton_physiology | 2.10169371 |
25 | MP0001819_abnormal_immune_cell | 2.07092377 |
26 | MP0002420_abnormal_adaptive_immunity | 2.05343752 |
27 | MP0004510_myositis | 2.02650905 |
28 | MP0000604_amyloidosis | 1.98675396 |
29 | MP0003191_abnormal_cellular_cholesterol | 1.95015254 |
30 | MP0005310_abnormal_salivary_gland | 1.87332493 |
31 | MP0000343_altered_response_to | 1.85896828 |
32 | MP0000685_abnormal_immune_system | 1.78933252 |
33 | MP0002405_respiratory_system_inflammati | 1.78923357 |
34 | MP0009764_decreased_sensitivity_to | 1.73529799 |
35 | MP0003448_altered_tumor_morphology | 1.71392596 |
36 | MP0005174_abnormal_tail_pigmentation | 1.68359135 |
37 | MP0001845_abnormal_inflammatory_respons | 1.67418838 |
38 | MP0008438_abnormal_cutaneous_collagen | 1.64701962 |
39 | MP0002998_abnormal_bone_remodeling | 1.64571433 |
40 | MP0003075_altered_response_to | 1.64384000 |
41 | MP0008469_abnormal_protein_level | 1.58419331 |
42 | MP0000015_abnormal_ear_pigmentation | 1.53848892 |
43 | MP0004947_skin_inflammation | 1.36997601 |
44 | MP0008004_abnormal_stomach_pH | 1.33307376 |
45 | MP0000716_abnormal_immune_system | 1.31924521 |
46 | MP0003183_abnormal_peptide_metabolism | 1.31256579 |
47 | MP0005167_abnormal_blood-brain_barrier | 1.30914879 |
48 | MP0002254_reproductive_system_inflammat | 1.27037026 |
49 | MP0002139_abnormal_hepatobiliary_system | 1.25858466 |
50 | MP0005166_decreased_susceptibility_to | 1.25609793 |
51 | MP0005257_abnormal_intraocular_pressure | 1.25048654 |
52 | MP0005171_absent_coat_pigmentation | 1.20851779 |
53 | MP0003300_gastrointestinal_ulcer | 1.19850440 |
54 | MP0000920_abnormal_myelination | 1.19011129 |
55 | MP0000689_abnormal_spleen_morphology | 1.18110428 |
56 | MP0009278_abnormal_bone_marrow | 1.16395740 |
57 | MP0000858_altered_metastatic_potential | 1.16067229 |
58 | MP0003806_abnormal_nucleotide_metabolis | 1.15550312 |
59 | MP0001853_heart_inflammation | 1.14725662 |
60 | MP0010155_abnormal_intestine_physiology | 1.13294855 |
61 | MP0002398_abnormal_bone_marrow | 1.09736874 |
62 | MP0002933_joint_inflammation | 1.08702201 |
63 | MP0003828_pulmonary_edema | 1.07637835 |
64 | MP0000465_gastrointestinal_hemorrhage | 1.05832135 |
65 | MP0005390_skeleton_phenotype | 1.04329371 |
66 | MP0002429_abnormal_blood_cell | 1.03210104 |
67 | MP0008260_abnormal_autophagy | 1.02758749 |
68 | MP0010307_abnormal_tumor_latency | 1.02382866 |
69 | MP0005451_abnormal_body_composition | 1.01039094 |
70 | MP0005164_abnormal_response_to | 1.00507706 |
71 | MP0001851_eye_inflammation | 0.97211389 |
72 | MP0006054_spinal_hemorrhage | 0.93087238 |
73 | MP0000371_diluted_coat_color | 0.92102199 |
74 | MP0003329_amyloid_beta_deposits | 0.91407080 |
75 | MP0002722_abnormal_immune_system | 0.90867069 |
76 | MP0005365_abnormal_bile_salt | 0.90343581 |
77 | MP0002006_tumorigenesis | 0.89463498 |
78 | MP0003195_calcinosis | 0.89408138 |
79 | MP0004782_abnormal_surfactant_physiolog | 0.88131128 |
80 | MP0002166_altered_tumor_susceptibility | 0.86911896 |
81 | MP0009333_abnormal_splenocyte_physiolog | 0.85695227 |
82 | MP0000249_abnormal_blood_vessel | 0.84413613 |
83 | MP0002638_abnormal_pupillary_reflex | 0.83883861 |
84 | MP0003866_abnormal_defecation | 0.83372959 |
85 | MP0001663_abnormal_digestive_system | 0.82971955 |
86 | MP0002090_abnormal_vision | 0.82592869 |
87 | MP0001958_emphysema | 0.81204691 |
88 | MP0003795_abnormal_bone_structure | 0.80649736 |
89 | MP0009763_increased_sensitivity_to | 0.80185319 |
90 | MP0010386_abnormal_urinary_bladder | 0.77405708 |
91 | MP0003763_abnormal_thymus_physiology | 0.73931116 |
92 | MP0003634_abnormal_glial_cell | 0.71500155 |
93 | MP0005197_abnormal_uvea_morphology | 0.71012918 |
94 | MP0004883_abnormal_blood_vessel | 0.70485038 |
95 | MP0001542_abnormal_bone_strength | 0.69497358 |
96 | MP0002295_abnormal_pulmonary_circulatio | 0.68293976 |
97 | MP0009765_abnormal_xenobiotic_induced | 0.68061403 |
98 | MP0003453_abnormal_keratinocyte_physiol | 0.68045940 |
99 | MP0002332_abnormal_exercise_endurance | 0.67551502 |
100 | MP0002136_abnormal_kidney_physiology | 0.63980600 |
101 | MP0005397_hematopoietic_system_phenotyp | 0.63471897 |
102 | MP0001545_abnormal_hematopoietic_system | 0.63471897 |
103 | MP0002132_abnormal_respiratory_system | 0.63141589 |
104 | MP0003566_abnormal_cell_adhesion | 0.61326090 |
105 | MP0002138_abnormal_hepatobiliary_system | 0.60286308 |
106 | MP0000767_abnormal_smooth_muscle | 0.60115438 |
107 | MP0005165_increased_susceptibility_to | 0.60102384 |
108 | MP0005083_abnormal_biliary_tract | 0.59376461 |
109 | MP0005076_abnormal_cell_differentiation | 0.58551811 |
110 | MP0005647_abnormal_sex_gland | 0.57760013 |
111 | MP0003279_aneurysm | 0.57324215 |
112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55004056 |
113 | MP0005388_respiratory_system_phenotype | 0.54424350 |
114 | MP0002133_abnormal_respiratory_system | 0.54424350 |
115 | MP0001324_abnormal_eye_pigmentation | 0.52712278 |
116 | MP0000609_abnormal_liver_physiology | 0.52649377 |
117 | MP0005319_abnormal_enzyme/_coenzyme | 0.52165815 |
118 | MP0003633_abnormal_nervous_system | 0.49213892 |
119 | MP0003656_abnormal_erythrocyte_physiolo | 0.48785481 |
120 | MP0003091_abnormal_cell_migration | 0.47855423 |
121 | MP0009697_abnormal_copulation | 0.47564297 |
122 | MP0001873_stomach_inflammation | 0.46410538 |
123 | MP0005275_abnormal_skin_tensile | 0.45458303 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 7.32165064 |
2 | Recurrent abscess formation (HP:0002722) | 7.07364292 |
3 | Increased cerebral lipofuscin (HP:0011813) | 6.20888754 |
4 | Vacuolated lymphocytes (HP:0001922) | 6.15230418 |
5 | Recurrent bacterial skin infections (HP:0005406) | 6.09109519 |
6 | Glomerulonephritis (HP:0000099) | 5.93182186 |
7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.66622117 |
8 | Eczematoid dermatitis (HP:0000976) | 5.46943112 |
9 | Abnormality of macrophages (HP:0004311) | 4.78083667 |
10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.75714727 |
11 | Disinhibition (HP:0000734) | 4.63906217 |
12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.54057060 |
13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.54057060 |
14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.54057060 |
15 | Axonal loss (HP:0003447) | 4.52715486 |
16 | Dysostosis multiplex (HP:0000943) | 4.43310083 |
17 | Prostate neoplasm (HP:0100787) | 4.06780328 |
18 | Complement deficiency (HP:0004431) | 4.05592611 |
19 | Thick nail (HP:0001805) | 3.89264959 |
20 | Gingivitis (HP:0000230) | 3.69090821 |
21 | Agnosia (HP:0010524) | 3.68128730 |
22 | Mediastinal lymphadenopathy (HP:0100721) | 3.64472069 |
23 | Abnormality of complement system (HP:0005339) | 3.62034023 |
24 | Recurrent skin infections (HP:0001581) | 3.49618499 |
25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.49128360 |
26 | Obstructive lung disease (HP:0006536) | 3.49128360 |
27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.46051039 |
28 | Autoimmune thrombocytopenia (HP:0001973) | 3.45672713 |
29 | Nephritis (HP:0000123) | 3.44055170 |
30 | Mucopolysacchariduria (HP:0008155) | 3.39404700 |
31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.39404700 |
32 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.38468880 |
33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.33459087 |
34 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.33459087 |
35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.33459087 |
36 | Myositis (HP:0100614) | 3.32453293 |
37 | Orchitis (HP:0100796) | 3.31949953 |
38 | Optic neuritis (HP:0100653) | 3.31018796 |
39 | Retrobulbar optic neuritis (HP:0100654) | 3.31018796 |
40 | Stomatitis (HP:0010280) | 3.28844605 |
41 | Basal ganglia calcification (HP:0002135) | 3.19387733 |
42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.10409539 |
43 | Upper motor neuron abnormality (HP:0002127) | 3.03905382 |
44 | Hemoptysis (HP:0002105) | 2.98240947 |
45 | Purpura (HP:0000979) | 2.81448935 |
46 | Pustule (HP:0200039) | 2.79813835 |
47 | Myocardial infarction (HP:0001658) | 2.76567715 |
48 | Recurrent fungal infections (HP:0002841) | 2.75894185 |
49 | Spontaneous hematomas (HP:0007420) | 2.72234444 |
50 | Loss of speech (HP:0002371) | 2.68704053 |
51 | Gastrointestinal infarctions (HP:0005244) | 2.65987302 |
52 | Pathologic fracture (HP:0002756) | 2.57829803 |
53 | Hepatosplenomegaly (HP:0001433) | 2.57633426 |
54 | T lymphocytopenia (HP:0005403) | 2.53561780 |
55 | Inappropriate behavior (HP:0000719) | 2.52540409 |
56 | Periodontitis (HP:0000704) | 2.51680732 |
57 | Urticaria (HP:0001025) | 2.45614384 |
58 | Recurrent viral infections (HP:0004429) | 2.43898025 |
59 | Encephalitis (HP:0002383) | 2.43434188 |
60 | Abnormality of T cell number (HP:0011839) | 2.39596329 |
61 | Osteomyelitis (HP:0002754) | 2.39514070 |
62 | Peripheral demyelination (HP:0011096) | 2.37677943 |
63 | Increased serum ferritin (HP:0003281) | 2.34149923 |
64 | Bone pain (HP:0002653) | 2.32586101 |
65 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.32106417 |
66 | Progressive visual loss (HP:0000529) | 2.31312066 |
67 | Gingival bleeding (HP:0000225) | 2.30979765 |
68 | Pulmonary infiltrates (HP:0002113) | 2.29291907 |
69 | Pulmonary embolism (HP:0002204) | 2.28386485 |
70 | Epistaxis (HP:0000421) | 2.27762688 |
71 | Vasculitis (HP:0002633) | 2.27171093 |
72 | Chest pain (HP:0100749) | 2.26857794 |
73 | Premature loss of primary teeth (HP:0006323) | 2.26810115 |
74 | Recurrent pneumonia (HP:0006532) | 2.26072326 |
75 | Polyneuropathy (HP:0001271) | 2.24113666 |
76 | Gangrene (HP:0100758) | 2.23526834 |
77 | Prolonged bleeding time (HP:0003010) | 2.17253200 |
78 | Hematochezia (HP:0002573) | 2.14589861 |
79 | Abnormality of iron homeostasis (HP:0011031) | 2.07465643 |
80 | Leukocytosis (HP:0001974) | 2.06758702 |
81 | Vertigo (HP:0002321) | 2.05339988 |
82 | Osteolytic defects of the hand bones (HP:0009699) | 2.05333995 |
83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05333995 |
84 | J-shaped sella turcica (HP:0002680) | 2.05161075 |
85 | Abnormality of the prostate (HP:0008775) | 2.04947348 |
86 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04929157 |
87 | Retinal atrophy (HP:0001105) | 2.04730545 |
88 | Recurrent cutaneous fungal infections (HP:0011370) | 2.03944468 |
89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.03944468 |
90 | Petechiae (HP:0000967) | 2.03847246 |
91 | Meningitis (HP:0001287) | 2.02788763 |
92 | Cellulitis (HP:0100658) | 2.01153758 |
93 | Global brain atrophy (HP:0002283) | 2.00227157 |
94 | Abnormality of the periventricular white matter (HP:0002518) | 1.98721486 |
95 | Hypokinesia (HP:0002375) | 1.98513193 |
96 | Anorexia (HP:0002039) | 1.98373353 |
97 | Conjunctival telangiectasia (HP:0000524) | 1.97836566 |
98 | Abnormality of the pleura (HP:0002103) | 1.94889386 |
99 | Episodic fever (HP:0001954) | 1.93996238 |
100 | Abnormality of the lumbar spine (HP:0100712) | 1.93310945 |
101 | Neurofibrillary tangles (HP:0002185) | 1.92453973 |
102 | Thoracic kyphosis (HP:0002942) | 1.91921007 |
103 | Increased CSF protein (HP:0002922) | 1.91086276 |
104 | Memory impairment (HP:0002354) | 1.90806464 |
105 | Apathy (HP:0000741) | 1.90260165 |
106 | Amaurosis fugax (HP:0100576) | 1.88262579 |
107 | Mutism (HP:0002300) | 1.88139622 |
108 | Keratoconjunctivitis sicca (HP:0001097) | 1.87468876 |
109 | Cerebral inclusion bodies (HP:0100314) | 1.87185149 |
110 | Personality changes (HP:0000751) | 1.85528797 |
111 | Progressive neurologic deterioration (HP:0002344) | 1.84077233 |
112 | Colitis (HP:0002583) | 1.82596251 |
113 | Joint hemorrhage (HP:0005261) | 1.80569267 |
114 | Recurrent lower respiratory tract infections (HP:0002783) | 1.80542415 |
115 | Inflammation of the large intestine (HP:0002037) | 1.80524236 |
116 | Diminished motivation (HP:0000745) | 1.78861210 |
117 | Eosinophilia (HP:0001880) | 1.76085759 |
118 | Spinal muscular atrophy (HP:0007269) | 1.74861167 |
119 | Supranuclear gaze palsy (HP:0000605) | 1.74722880 |
120 | Neuronal loss in central nervous system (HP:0002529) | 1.73306621 |
121 | Amyloidosis (HP:0011034) | 1.70781903 |
122 | Keratoconjunctivitis (HP:0001096) | 1.67797395 |
123 | Arterial tortuosity (HP:0005116) | 1.67748936 |
124 | Arterial thrombosis (HP:0004420) | 1.65009121 |
125 | Interstitial pulmonary disease (HP:0006530) | 1.64360133 |
126 | Sepsis (HP:0100806) | 1.64153225 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 5.41219073 |
2 | RIPK4 | 4.06191884 |
3 | MAP3K14 | 3.69542163 |
4 | KIT | 3.51939496 |
5 | TYK2 | 3.28751203 |
6 | IRAK3 | 3.14015217 |
7 | IRAK4 | 3.04038912 |
8 | TBK1 | 3.03515957 |
9 | TXK | 2.46635465 |
10 | TGFBR2 | 2.43962825 |
11 | IKBKE | 2.41833775 |
12 | MAP4K1 | 2.39520338 |
13 | IKBKB | 2.11157463 |
14 | PBK | 2.04780745 |
15 | JAK1 | 1.98753589 |
16 | FES | 1.81281901 |
17 | TAOK3 | 1.80525046 |
18 | ACVR1B | 1.78526400 |
19 | GRK7 | 1.76039623 |
20 | LYN | 1.60345430 |
21 | CSF1R | 1.55198808 |
22 | SYK | 1.53088699 |
23 | FGR | 1.50510663 |
24 | JAK3 | 1.50081936 |
25 | HCK | 1.49767768 |
26 | ZAP70 | 1.44905285 |
27 | CSK | 1.44873439 |
28 | BMPR2 | 1.43685994 |
29 | NEK9 | 1.36674745 |
30 | YES1 | 1.27927543 |
31 | LCK | 1.24080040 |
32 | NME2 | 1.11816961 |
33 | MAP3K11 | 1.10900179 |
34 | DDR2 | 1.08068325 |
35 | ERN1 | 1.05447058 |
36 | MAP3K1 | 1.04123323 |
37 | TEC | 1.03970203 |
38 | PIM2 | 1.03529282 |
39 | CDC42BPA | 1.02594404 |
40 | MST4 | 1.02343943 |
41 | MAP3K13 | 1.02321454 |
42 | TAOK1 | 1.02214167 |
43 | BRD4 | 1.00801647 |
44 | SCYL2 | 1.00508749 |
45 | EIF2AK2 | 0.99221481 |
46 | TRPM7 | 0.94814961 |
47 | CAMK1D | 0.94349239 |
48 | CHUK | 0.94164120 |
49 | GRK6 | 0.93239169 |
50 | JAK2 | 0.90266485 |
51 | PRKCD | 0.87396336 |
52 | BTK | 0.85556478 |
53 | EGFR | 0.85423070 |
54 | NUAK1 | 0.83658475 |
55 | PDPK1 | 0.83003056 |
56 | TAOK2 | 0.81936078 |
57 | EPHB1 | 0.80971910 |
58 | PDK1 | 0.80232528 |
59 | MATK | 0.79820870 |
60 | MAP2K3 | 0.77391929 |
61 | ADRBK2 | 0.76758195 |
62 | DAPK2 | 0.74103526 |
63 | MAP3K3 | 0.72760428 |
64 | SIK2 | 0.72081954 |
65 | ERBB3 | 0.72037601 |
66 | ITK | 0.70883869 |
67 | ABL1 | 0.69449942 |
68 | CAMKK2 | 0.69307337 |
69 | KSR2 | 0.68217097 |
70 | CLK1 | 0.67912025 |
71 | FYN | 0.66201356 |
72 | BMX | 0.64720696 |
73 | PDK2 | 0.63813380 |
74 | PLK2 | 0.63769435 |
75 | BMPR1B | 0.63736105 |
76 | PIM1 | 0.63186005 |
77 | CAMK1G | 0.61621954 |
78 | PIK3CG | 0.58854306 |
79 | MST1R | 0.58624802 |
80 | MAP3K6 | 0.58371918 |
81 | EPHA3 | 0.58124187 |
82 | RIPK1 | 0.55164435 |
83 | PKN1 | 0.53918798 |
84 | IGF1R | 0.53137051 |
85 | MOS | 0.51178087 |
86 | TNK2 | 0.49489568 |
87 | MARK2 | 0.47842719 |
88 | ABL2 | 0.46912550 |
89 | IRAK2 | 0.46756531 |
90 | MAP3K2 | 0.46245022 |
91 | STK3 | 0.43547671 |
92 | MAP3K5 | 0.43048998 |
93 | PRPF4B | 0.42400385 |
94 | MARK3 | 0.41896651 |
95 | TTN | 0.40599663 |
96 | IRAK1 | 0.40375816 |
97 | MAP2K6 | 0.39495294 |
98 | HIPK2 | 0.39168641 |
99 | RPS6KA2 | 0.38295941 |
100 | RPS6KA4 | 0.37837794 |
101 | STK10 | 0.36951162 |
102 | FGFR3 | 0.36719041 |
103 | SGK3 | 0.36691778 |
104 | SIK3 | 0.36067999 |
105 | MAPK4 | 0.35701743 |
106 | PRKCQ | 0.35044198 |
107 | PRKCE | 0.34465121 |
108 | PAK4 | 0.34029543 |
109 | CDK6 | 0.33691769 |
110 | PRKG1 | 0.31658081 |
111 | PRKD1 | 0.31241657 |
112 | MAPK12 | 0.30901085 |
113 | SGK2 | 0.30632690 |
114 | RPS6KA6 | 0.30221111 |
115 | INSR | 0.29910582 |
116 | KSR1 | 0.29522437 |
117 | ARAF | 0.29364883 |
118 | MAPK7 | 0.29156523 |
119 | RPS6KL1 | 0.28730892 |
120 | RPS6KC1 | 0.28730892 |
121 | INSRR | 0.28235549 |
122 | MAPKAPK2 | 0.28057378 |
123 | TGFBR1 | 0.27609499 |
124 | CAMKK1 | 0.25392632 |
125 | PDGFRB | 0.25302917 |
126 | PRKG2 | 0.24916476 |
127 | SRC | 0.23337935 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.77148067 |
2 | Lysosome_Homo sapiens_hsa04142 | 3.57449796 |
3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.22470212 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.95677973 |
5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.74721189 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.68054552 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.50819318 |
8 | Pertussis_Homo sapiens_hsa05133 | 2.41889155 |
9 | Phagosome_Homo sapiens_hsa04145 | 2.36969338 |
10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.36319581 |
11 | Tuberculosis_Homo sapiens_hsa05152 | 2.31113709 |
12 | Malaria_Homo sapiens_hsa05144 | 2.03355720 |
13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.03106497 |
14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.96039084 |
15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.87668407 |
16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77322826 |
17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77255089 |
18 | Legionellosis_Homo sapiens_hsa05134 | 1.73402935 |
19 | Measles_Homo sapiens_hsa05162 | 1.73136880 |
20 | Asthma_Homo sapiens_hsa05310 | 1.64607213 |
21 | Allograft rejection_Homo sapiens_hsa05330 | 1.61669517 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59208384 |
23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.58365085 |
24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57495888 |
25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56779450 |
26 | Salmonella infection_Homo sapiens_hsa05132 | 1.54181390 |
27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45134137 |
28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42557996 |
29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.40851587 |
30 | Influenza A_Homo sapiens_hsa05164 | 1.40539675 |
31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37020531 |
32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36623329 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31732565 |
34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31152493 |
35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29880699 |
36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28181353 |
37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27207774 |
38 | Apoptosis_Homo sapiens_hsa04210 | 1.23957498 |
39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.23205417 |
40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22058304 |
41 | Prion diseases_Homo sapiens_hsa05020 | 1.18320303 |
42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13824566 |
43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13623671 |
44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05169555 |
45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04019753 |
46 | Mineral absorption_Homo sapiens_hsa04978 | 1.00612181 |
47 | Shigellosis_Homo sapiens_hsa05131 | 0.96620699 |
48 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96002687 |
49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94115350 |
50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85747910 |
51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85674479 |
52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84227640 |
53 | Hepatitis C_Homo sapiens_hsa05160 | 0.83746058 |
54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81150601 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 0.76078770 |
56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74737852 |
57 | Amoebiasis_Homo sapiens_hsa05146 | 0.71586262 |
58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67432625 |
59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66743066 |
60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65322102 |
61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64701949 |
62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62859171 |
63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62823453 |
64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61274531 |
65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57074382 |
66 | Endocytosis_Homo sapiens_hsa04144 | 0.55897273 |
67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54968988 |
68 | Platelet activation_Homo sapiens_hsa04611 | 0.54003569 |
69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52362476 |
70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51139106 |
71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49149997 |
72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.44538454 |
73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43809157 |
74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42944287 |
75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42938021 |
76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42599202 |
77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.41619781 |
78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40566210 |
79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39576097 |
80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38711429 |
81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38097544 |
82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37752497 |
83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37058423 |
84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35364368 |
85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34423645 |
86 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.34150143 |
87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.33566542 |
88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33393013 |
89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.32359510 |
90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32133753 |
91 | Bladder cancer_Homo sapiens_hsa05219 | 0.30287884 |
92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29653774 |
93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28278796 |
94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28172442 |
95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28039567 |
96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.26318159 |
97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25568972 |
98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24944503 |
99 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.24816692 |
100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24299400 |
101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22888408 |
102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.22348054 |
103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.22097465 |
104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19911410 |
105 | ABC transporters_Homo sapiens_hsa02010 | 0.19253406 |
106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18860981 |
107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18688391 |
108 | Insulin resistance_Homo sapiens_hsa04931 | 0.17594127 |
109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17495347 |
110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15617480 |
111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15122725 |
112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.14805215 |
113 | Melanoma_Homo sapiens_hsa05218 | 0.12511603 |
114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.11091169 |
115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.09168557 |